SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-23-000519
Filing Date
2023-01-11
Accepted
2023-01-11 16:05:20
Documents
2
Period of Report
2023-01-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-58159.html 3  
1 PRIMARY DOCUMENT marketforms-58159.xml 3 8640
2 POA DOCUMENT poa.htm EX-24 2976
  Complete submission text file 0001214659-23-000519.txt   13067
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Wargacki Stephen (Reporting) CIK: 0001960165 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38599 | Film No.: 23523637